Could semiquantitative FDG analysis add information to the prognosis in patients with stage II/III breast cancer undergoing neoadjuvant treatment?
Crossref DOI link: https://doi.org/10.1007/s00259-015-3088-4
Published Online: 2015-05-31
Published Print: 2015-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Evangelista, Laura
Cervino, Anna Rita
Ghiotto, Cristina
Saibene, Tania
Michieletto, Silvia
Fernando, Bozza
Orvieto, Enrico
Guarneri, Valentina
Conte, Pierfranco
Text and Data Mining valid from 2015-05-31